All (n=155)
No bacteraemia (n=140, 90.3%)
Bacteraemia (n=15, 9.7%)
p-value
Follow-up (days) 623 (358 – 1061) 621 (402 – 1035) 649 (233 – 1140) 0.540
Age (y) 83.0 (77.0 – 87.0) 83.0 (78.0 – 87.0) 81.0 (77.0 – 82.0) 0.077
Male 96 (61.9%) 86 (61.4%) 10 (66.7%) 0.691
BMI (kg/m²) 25.9 (23.8 – 28.5) 25.9 (23.8 – 28.5) 25.7 (23.5 – 28.4) 0.896
History of AF 93 (60.0%) 82 (58.6%) 11 (73.3%) 0.267
Indication for pacing
High degree AV block
81 (52.3%)
72 (51.4%)
9 (60.0%)
0.432
Sick sinus syndrome
21 (13.5%)
18 (12.9%)
3 (20.0%)
AF with bradycardia
53 (34.2%)
50 (35.7%)
3 (20.0%)
Anticoagulation
103 (66.5%)
91 (65.0%)
12 (80.0%)
0.242
CHADS-VASc
4.0 (3.0 – 5.0)
4.0 (3.0 – 5.0)
4.0 (3.0 – 5.0)
0.421
Creatinine (mg/dL) 1.11 (0.91 – 1.41) 1.09 (0.89 – 1.39) 1.37 (0.97 – 2.06) 0.070
Renal function (eGFR, mL/min) 60.7 (45.0 – 77.0) 61.6 (46.0 – 77.0) 50.1 (36.3 – 69.2) 0.182
Dialysis 8 (5.2%) 5 (3.6%) 3 (20.0%) 0.006
LVEF (%) 55.0 (53.0 – 60.0) 55.0 (54.5 – 60.0) 60.0 (56.3 – 60.0) 0.052
Arterial hypertension 111 (71.6%) 99 (70.7%) 12 (80.0%) 0.448
Coronary artery disease 54 (34.8%) 49 (35.0%) 5 (33.3%) 0.898
COPD / pulmonary fibrosis 16 (10.3%) 14 (10.0%) 2 (13.3%) 0.687
Chronic cortisone use 11 (7.1%) 10 (7.1%) 1 (6.7%) 0.946
Diabetes Mellitus 37 (23.9%) 33 (23.6%) 4 (26.7%) 0.789
History of heart failure 19 (12.3%) 18 (12.9%) 1 (6.7%) 0.487
History of valve intervention 49 (31.6%) 39 (27.9%) 10 (66.7%) 0.002
History of pacemaker extraction due to infection 13 (8.4%) 12 (8.6%) 1 (6.7%) 0.800
Implant procedure duration (min) 42.0 (36.0 – 58.0) 43.0 (36.0 – 58.8) 38.0 (33.0 – 50.0) 0.261
Device redeployments during the implantation
0 110 (71.0%) 99 (70.7%) 11 (73.3%) 0.849
1 28 (18.0%) 25 (17.9%) 3 (20.0%) 0.849
≥2 17 (11.0%) 16 (11.4%) 1 (6.7%)